CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C308. A total of 87 filers reported holding CORMEDIX INC in Q2 2023. The put-call ratio across all filers is 2.54 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,225 | +138.5% | 31,142 | +155.6% | 0.00% | – |
Q2 2023 | $48,310 | +1984.1% | 12,184 | +2075.7% | 0.00% | – |
Q1 2023 | $2,318 | -15.6% | 560 | -14.0% | 0.00% | – |
Q4 2022 | $2,747 | -99.9% | 651 | -2.5% | 0.00% | – |
Q3 2022 | $1,890,000 | -97.3% | 668 | -96.2% | 0.00% | – |
Q2 2022 | $70,909,000 | +105.9% | 17,639 | +180.7% | 0.00% | – |
Q1 2022 | $34,436,000 | -48.3% | 6,284 | -57.1% | 0.00% | – |
Q4 2021 | $66,639,000 | +58.1% | 14,646 | +61.5% | 0.00% | – |
Q3 2021 | $42,157,000 | +87.3% | 9,066 | +176.3% | 0.00% | – |
Q2 2021 | $22,508,000 | -42.6% | 3,281 | -16.4% | 0.00% | – |
Q1 2021 | $39,191,000 | -3.2% | 3,923 | -28.0% | 0.00% | – |
Q4 2020 | $40,479,000 | +4.8% | 5,448 | -15.0% | 0.00% | – |
Q3 2020 | $38,634,000 | +579.1% | 6,407 | +609.5% | 0.00% | – |
Q2 2020 | $5,689,000 | -79.9% | 903 | -88.5% | 0.00% | – |
Q1 2020 | $28,293,000 | +6.5% | 7,881 | +116.0% | 0.00% | – |
Q4 2019 | $26,565,000 | +39.0% | 3,649 | +21.8% | 0.00% | – |
Q3 2019 | $19,108,000 | +3127.7% | 2,995 | +4437.9% | 0.00% | – |
Q2 2019 | $592,000 | – | 66 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spinnaker Capital LLC | 175,384 | $649 | 100.00% |
PLANNING DIRECTIONS INC | 50,000 | $185 | 0.14% |
Castellan Group | 30,000 | $110,700 | 0.08% |
Wick Capital Partners, LLC | 35,985 | $133,145 | 0.08% |
GSG Advisors LLC | 30,000 | $111,000 | 0.05% |
Elliott Investment Management L.P. | 1,550,523 | $5,736,935 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 74,763 | $276,623 | 0.04% |
NOMURA HOLDINGS INC | 2,951,532 | $10,920,668 | 0.03% |
American Financial Advisors, LLC | 30,527 | $112,950 | 0.02% |
Advisor OS, LLC | 25,000 | $92,500 | 0.01% |